Data last refreshed 190 days ago — analysis may not reflect the latest market data

—FIS

— • —

NEUTRAL

$43.37

P/E

59.74

PEG

—

FCF Yield

—

Rev Growth YoY

+543.0% YoY

Gross Margin

3686.0%

Health Score

4/10

D/E Ratio

0.94

Confidence

—


Advertisement

Business Snapshot

The ticker and company name were not provided in this data payload, which limits contextual background. Based on the available financial data, this appears to be a company with a Price/Sales ratio of 2.15x and a P/E of 59.74x, suggesting it operates in a growth-oriented segment. Without a confirmed market capitalisation figure, precise cap-tier classification cannot be made, though the valuation profile and data characteristics are consistent with a smaller or emerging-stage company.

Advertisement

Financial Health

Score: 4/10

The financial health picture is mixed and warrants caution. The gross margin stands at an extraordinary 3,686% and net margin at 357%, which are statistically anomalous figures that likely reflect accounting distortions, one-time items, or non-standard revenue recognition rather than genuine operational efficiency...

Risk Assessment

  • VALUATION: P/E of 59.74x is approximately 2.4x the sector average of 25x, with no PEG or DCF estimate to justify the premium.
  • LIQUIDITY: Current ratio of 0.59x indicates the company may struggle to meet near-term obligations, falling well below the conventional safe threshold of 1.0x.
  • EARNINGS DETERIORATION: Earnings growth of -7,203% year-over-year represents a severe bottom-line collapse that directly contradicts the strong revenue headline.
  • DATA QUALITY: Gross margin of 3,686% and net margin of 357% are statistically implausible for most industries and suggest possible data anomalies, restatements, or non-standard accounting.
  • TECHNICAL WEAKNESS: A confirmed death cross (50-day MA crossing below 200-day MA) combined with a bearish MACD signal indicates prevailing downside momentum in the share price.

---...

**Score: 4/10** The financial health picture is mixed and warrants caution. The gross margin stands at an extraordinary 3,686% and net margin at 357%, which are statistically anomalous figures that likely reflect accounting distortions, one-time items, or non-standard revenue recognition rather than genuine operational efficiency. The current ratio of 0.59x signals a meaningful short-term liquidity concern — the company holds less than $0.60 in current assets for every $1.00 of current liabilities — while free cash flow is unavailable, making it impossible to assess whether operations are self-funding. ---

- **VALUATION: P/E of 59.74x is approximately 2.4x the sector average of 25x, with no PEG or DCF estimate to justify the premium.** - **LIQUIDITY: Current ratio of 0.59x indicates the company may struggle to meet near-term obligations, falling well below the conventional safe threshold of 1.0x.** - **EARNINGS DETERIORATION: Earnings growth of -7,203% year-over-year represents a severe bottom-line collapse that directly contradicts the strong revenue headline.** - **DATA QUALITY: Gross margin of 3,686% and net margin of 357% are statistically implausible for most industries and suggest possible data anomalies, restatements, or non-standard accounting.** - **TECHNICAL WEAKNESS: A confirmed death cross (50-day MA crossing below 200-day MA) combined with a bearish MACD signal indicates prevailing downside momentum in the share price.** ---

Unlock the full AI report

Full 8-section analysis includes:

Financial Health
Growth Momentum
Valuation Snapshot
Risk Flags
Sentiment & News
Technical Snapshot
Full Verdict with Confidence Rating
Last updated 4575 hours ago · Data sourced from FMP & Finnhub · Not financial advice